SciHub
文献互助
期刊查询
一搜即达
科研导航
交流社区
登录
注册
发布
文献
求助
首页
我的求助
捐赠本站
哒哒哒
Lv1
70 积分
2023-11-10 加入
最近求助
最近应助
互助留言
Comparative safety of immune checkpoint inhibitors and chemotherapy in advanced non-small cell lung cancer: A systematic review and network meta-analysis
10天前
已完结
Brain metastases and immune checkpoint inhibitors in non-small cell lung cancer: a systematic review and meta-analysis
10天前
已完结
Comparative Efficacy of Treatments for Brain Metastases from Non–Small Cell Lung Cancer without an EGFR-Mutation/ALK-Rearrangement: A Systematic Review and Network Meta-Analysis
10天前
已完结
Immunotherapy in NSCLC Patients with Brain Metastases
11天前
已完结
Treatments for brain metastases from EGFR/ALK-negative/unselected NSCLC: A network meta-analysis
17天前
已关闭
Tiragolumab plus atezolizumab versus placebo plus atezolizumab as a first-line treatment for PD-L1-selected non-small-cell lung cancer (CITYSCAPE): primary and follow- up analyses of a randomised, double-blind, phase 2 study
20天前
已完结
Tiragolumab plus atezolizumab versus placebo plus atezolizumab as a first-line treatment for PD-L1-selected non-small-cell lung cancer (CITYSCAPE): primary and follow-up analyses of a randomised, double-blind, phase 2 study
20天前
已完结
PD-1 iNhibitor and chemotherapy with concurrent IRradiation at VAried tumor sites in advanced Non-small cell lung cAncer: the Prospective Randomized Phase 3 NIRVANA-Lung Trial
20天前
已完结
Final overall survival data of sintilimab plus pemetrexed and platinum as First-Line treatment for locally advanced or metastatic nonsquamous NSCLC in the Phase 3 ORIENT-11 study
21天前
已关闭
Final overall survival data of sintilimab plus pemetrexed and platinum as First-Line treatment for locally advanced or metastatic nonsquamous NSCLC in the Phase 3 ORIENT-11 study
22天前
已完结
没有进行任何应助
已找到文章【积分已退回】
17天前
需要的是增补文件哦
21天前
最近帖子
最近评论
没有发布任何帖子
没有发布任何评论